Some slides today...
Notice the fundamental change from IPO (at double teh market cap) and the assets growing...
Someone asked when CHM will reduce Revenue/commercialisation. JC said about 5 years away. Just let that sink in.
People seem to invest in Biotech not realising the long runway. Yet if CHM did achieve substantial revenue in 5 years even that would be quite quick for a bio.
Add to My Watchlist
What is My Watchlist?